Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. T.NVC


Primary Symbol: NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

Bullboard Posts
Post by BCBABY2014on Nov 23, 2016 1:16pm
136 Views
Post# 25503247

Institutional investors and hedge funds own 23.58% of the co

Institutional investors and hedge funds own 23.58% of the coSeveral institutional investors have recently made changes to their positions in the company. Geduld E E raised its position in shares of Neovasc by 133.3% in the third quarter. Geduld E E now owns 350,000 shares of the company’s stock worth $184,000 after buying an additional 200,000 shares during the period. Gagnon Securities LLC raised its position in shares of Neovasc by 18.2% in the second quarter. Gagnon Securities LLC now owns 2,431,837 shares of the company’s stock worth $1,253,000 after buying an additional 375,243 shares during the period. Capital World Investors raised its position in shares of Neovasc by 5.1% in the second quarter. Capital World Investors now owns 5,345,736 shares of the company’s stock worth $2,808,000 after buying an additional 261,443 shares during the period. Finally, Gagnon Advisors LLC raised its position in shares of Neovasc by 46.2% in the second quarter. Gagnon Advisors LLC now owns 1,892,125 shares of the company’s stock worth $975,000 after buying an additional 597,906 shares during the period. Institutional investors and hedge funds own 23.58% of the company’s stock.
Bullboard Posts